Redistributed Manufacturing in Deployed Medical Care Network Plus

部署医疗保健网络中的再分配制造

• 批准号: EP/T014970/1
• 负责人: Wendy Phillips
• 金额: $ 221.89万
• 依托单位: University of the West of England
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=EP%2FT014970%2F1
• 关键词: Redistributed; Manufacturing; Deployed; Medical; Care

Re-Distributed Manufacture (RDM) is defined as: "Technology, systems and strategies that change the economics and organisation of manufacturing, particularly with regard to location and scale" . In healthcare, RDM involves bringing production closer to the point of clinical need or use, enhancing the capability to deliver personalised medicine. The EPSRC funded Re-Distributed Manufacturing in Healthcare Network (RiHN- www.RiHN.org.uk) was launched in Feb 2015 and delivered by a consortium of six universities (UWE, Loughborough, Nottingham, Cambridge, Newcastle & Brunel), representing disciplines from both the social sciences and engineering and led an agenda to advance the impact of UK medical manufacturing. One area of significant research interest identified by RiHN has been the potential value of implementing RDM approaches in deployed medical care. Whilst RDM includes the notion of a shift from centralised towards decentralised production, extant research continues to assume a degree of stable environmental conditions and fixed static location (e.g. hospitals/clinics/home). However, RDM can deliver life-saving benefits in mobile medical scenarios, where there is urgent and unforeseen demand in changing and remote locations, such as in response to natural disasters and emergencies (e.g. the Ebola crisis, Cyclone Idai and recent terrorist attacks), and the rapid treatment of injured military personnel in the field. This often requires a reverse supply chain perspective, starting with the requirement based on patient need. There are a variety of medical conditions that could benefit from rapid response treatments closer to the site of a medical emergency or in field hospitals; these include (but not limited to) blast injuries to skin and tissue, haemorrhagic shock and fractures.The project will be led by a multi-disciplinary team bringing together subject matter experts that rarely meet, such as experts in trauma care, emergency medicine, innovation management and manufacturing, and will achieve the following outputs:- A review of current research capability and knowledge- sharing of current breakthroughs- Enhancing understanding of the use of RDM in deployed medical care- Identification of and development of promising RDM technologies that support treatment pathways in deployed operations- Capture of military and civilian emergency medical requirements and applications for RDM- Systematic identification and comparison of needs, applications, technologies and resourcesThe overall outcome for the research will be the creation of 'communities of practice', producing real world demonstrators covering both the business and technical aspects of implementing RDM in deployed medical care, bringing the potential to advance the UK's capability in RDM, delivering impact to clinicians, practitioners and patients. The research will help shape how the UK Ministry of Defence, prime contractors in the defence sector, emergency and urgent care services and UK Research Council proceed with future R&D investment and resourcing. The outputs of the project will also be disseminated through a website, presentations at relevant national and international conferences, and research centres and a Special Issue journal (Health Services Management Research) and presenting the findings of the project at a showcase event. A final report will be produced, sent electronically to all interested parties, and made available digitally and via social media.

再分布式制造（RDM）被定义为：“改变制造经济和组织的技术、系统和策略，特别是在位置和规模方面”。在医疗保健领域，RDM 涉及使生产更接近临床需求或使用点，从而增强提供个性化医疗的能力。 EPSRC 资助的医疗保健网络中的重新分布式制造 (RiHN-www.RiHN.org.uk) 于 2015 年 2 月启动，由六所大学（西英格兰大学、拉夫堡大学、诺丁汉大学、剑桥大学、纽卡斯尔大学和布鲁内尔大学）组成的联盟提供，代表社会科学和工程学科，并领导了一项旨在提高英国医疗制造影响力的议程。 RiHN 确定的一个重要研究兴趣领域是在部署的医疗保健中实施 RDM 方法的潜在价值。虽然 RDM 包括从集中式生产向分散式生产转变的概念，但现有研究仍然假设一定程度的稳定环境条件和固定的静态位置（例如医院/诊所/家庭）。然而，RDM 可以在移动医疗场景中带来拯救生命的好处，在这些场景中，在不断变化的偏远地点存在紧急和不可预见的需求，例如应对自然灾害和紧急情况（例如埃博拉危机、飓风伊代和最近的恐怖袭击），以及在现场快速治疗受伤军事人员。这通常需要逆向供应链视角，从基于患者需求的要求开始。有多种医疗状况可以受益于靠近医疗紧急情况现场或野战医院的快速反应治疗；这些包括（但不限于）皮肤和组织爆炸伤、失血性休克和骨折。该项目将由一个多学科团队领导，该团队汇集了很少见面的主题专家，例如创伤护理、急诊医学、创新管理和制造方面的专家，并将实现以下成果： - 回顾当前的研究能力和知识 - 共享当前的突破 - 增强对 RDM 在 部署的医疗保健 - 确定和开发有前途的 RDM 技术，支持部署行动中的治疗途径 - 捕获军事和民用紧急医疗需求和 RDM 的应用 - 系统地识别和比较需求、应用、技术和资源 研究的总体成果将是创建“实践社区”，产生现实世界的演示者，涵盖在部署的医疗保健中实施 RDM 的业务和技术方面， 带来提升英国 RDM 能力的潜力，为临床医生、从业者和患者带来影响。该研究将有助于确定英国国防部、国防部门的主要承包商、紧急和紧急护理服务以及英国研究委员会如何进行未来的研发投资和资源配置。该项目的成果还将通过网站、在相关国内和国际会议、研究中心和特刊期刊（卫生服务管理研究）上的演讲以及在展示活动中展示该项目的研究结果进行传播。最终报告将被制作出来，以电子方式发送给所有感兴趣的各方，并通过数字方式和社交媒体提供。

项目成果

Healthcare Innovation - Shaping Future Models of Delivery

医疗保健创新 - 塑造未来的交付模式

• DOI: 10.1142/9781800614192_0009
• 发表时间: 2023
• 作者: Kapletia D

Implantable Technologies - Peptides and Small Molecules Drug Delivery

植入技术 - 肽和小分子药物输送

• DOI: 10.1039/9781839164958-00252
• 发表时间: 2021
• 作者: Qi S

Global Value Chain Reconfiguration and COVID-19: Investigating the Case for More Resilient Redistributed Models of Production

全球价值链重构和 COVID-19：研究更具弹性的生产重新分配模式的案例

• DOI: 10.1177/00081256211068545
• 发表时间: 2022
• 期刊: California Management Review
• 影响因子: 10
• 作者: Phillips W

Responding to information asymmetry in crisis situations: innovation in the time of the COVID-19 pandemic

• DOI: 10.1080/14719037.2021.1960737
• 发表时间: 2021-08
• 期刊: Public Management Review
• 影响因子: 4.9
• 作者: W. Phillips;J. Roehrich;Dharm Kapletia

Innovation in healthcare manufacturing: transforming deployed medical care

医疗保健制造创新：改变部署的医疗保健

• 发表时间: 2020
• 作者: Phillips W